The recent approval of Aduhelm, a drug that removes amyloid plaques from the brains of people with Alzheimer’s, is a reason for cautious celebration. Not just because it is the first new treatment approved in 17 years, but because it is the first piece of a complex puzzle that researchers are hot on the trail of solving.
Read MoreCommentary: Alzheimer’s Research Pipeline Is Poised to Conquer Alzheimer’s with Combination Drug Treatments
